Cargando…
β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
Autores principales: | Karimi, Mehran, Haghpanah, Sezaneh, Taher, Ali T., Cappellini, Maria Domenica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457590/ https://www.ncbi.nlm.nih.gov/pubmed/23019522 http://dx.doi.org/10.1155/2012/902067 |
Ejemplares similares
-
Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014) -
Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014) -
Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023) -
Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2010) -
Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)